Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology
Reference76 articles.
1. Nguyen P.L., Gu X., Lipsitz S.R., et al: Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol 29:1517-1524, 2011
2. What does “FDA Approved” mean for medical devices?;Nygaard;Obstet Gynecol,2008
3. Katz A, Freeman D, Aronovitz J, et al: Five-year biochemical control rates for stereotactic body radiation therapy for organ-confined prostate cancer: A multi-institutional pooled analysis. Int J Radiat Oncol Biol Phys 84:S147-S148, 2012
4. Conformal intensity-modulated radiotherapy (IMRT) delivered by robotic linac—Testing IMRT to the limit?;Webb;Phys Med Biol,1999
5. Stereotactic body radiotherapy for localized prostate cancer: Interim results of a prospective phase II clinical trial;King;Int J Radiat Oncol Biol Phys,2009
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献